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Stroke following endovenous laser treatment of
varicose veins
Alberto Caggiati and Marco Franceschini, Rome, Italy
This report describes an ischemic stroke following endovenous laser treatment of the great saphenous vein in a patient
with a patent foramen ovale. No thrombophilic conditions or other possible sources of emboli could be demonstrated.
(J Vasc Surg 2010;51:218-20.)Endovenous laser treatment (EVLT) is currently used
in selected patients for the ablation of lower extremity
varicose veins. First attempts of EVLT date back to 1989 by
Puglisi,1 but it was in 1999 that Boné2 reported on the
successful use of diode laser in the treatment of great saphe-
nous vein (GSV) reflux. Moreover, many reports about the
efficacy and safety of EVLT have been published.3 Contin-
uous technological and methodological improvements
have determined reduction of morbidity which is currently
considered lower than with conventional GSV stripping.4
Major complications were rarely reported.5
This report describes an ischemic stroke following
EVLT of a varicose GSV.
CASE REPORT
On April 10, 2008, a 59-year-old Caucasian woman under-
went EVLT of the right GSV for primary varicose veins at another
institution. Her medical history included left mastectomy (1981)
followed by mammary reconstruction. She did not take medication.
Preoperative coagulative evaluations (blood cell count, antithrombin
3, prothrombin time, activated partial prothrombin time, and fibrin-
ogen) were normal. Her initial duplex ultrasound (DUS) study
demonstrated right sapheno-femoral junction (SFJ) incompetence
with GSV reflux. The caliber of the GSV was not reported.
Endovenous laser ablation of the right GSV was performed
under local anaesthesia with mild sedation (midazolam, 2 mg), by
a 600 micrometer fiber connected to a 980 nm diode laser source
operating at 8 watts. The fiber was pushed up to the groin just
below the orifice of the inferior epigastric and operated under
echoguide. Pull-out rate of the fiber was 1 mm/sec, with a con-
tinuous emission (energy delivered 78J/cm). At the end of the
procedure, a single dose of low molecular weight heparin
(LMWH; nadroparin, 03 ml) was administered subcutaneously
and a class II elastic stocking was applied. The postoperative report
confirmed successful obliteration of the treated segment of the
GSV without complication. One hour after the end of the proce-
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218dure, the patient was able to walk. No signs or symptoms of deep
vein thrombosis (DVT) were noted at discharge.
On the evening of April 15, the patient reported unspecific
visual disturbances and on the next morning she suddenly devel-
oped right side hemiparesis with global aphasia. A brain computed
tomography (CT) was negative for hemorrhage. Trans cranial
Doppler (TCD) demonstrated complete occlusion of the left mid-
dle cerebral artery (MCA) at its origin but DUS of carotid arteries
did not show occlusions, stenosis, or other possible sources of
emboli. Pharmacologic treatment was adjuvated by sonothrom-
bolysis enhanced with endovenous administration of five bolus of
sulphur hexafluoride-filled microbubbles. The day after, also the
A1 segment of the anterior cerebral artery (ACA) was occluded and
sonothrombolysis repeated. Four days after the stroke, TCD dem-
onstrated “recanalization of the ACA, occlusion of the MCA with
compensatory increase of flow in the left posterior cerebral.” Brain
CT showed an extensive hypodense area in the territory of distri-
bution of the frontoparietal branches of the MCA (Fig 1). On April
24, both legs were investigated by Duplex ultrasound but no
thrombosis could be found in deep, superficial, and calf veins. In
turn, transesophageal echocardiography (TEE) showed patent fo-
ramen ovale (PFO) with an associated atrial septal aneurism (type
IC). The bubble test demonstrated a grade 3 right-to-left shunt in
basal conditions. One month after the stroke, TCD demonstrated
the recanalization of the M1 segment of the MCA, with high
resistance in the M2 tract. Finally, the PFO was corrected percu-
taneously, by BioSTAR 28 mm NMT Medical Inc, Boston, Mass).
One year after the stroke, she still suffers from aphasia and
severe hemiparesis. No cancer recurrence or other malignancies
could be demonstrated. Hematologic investigations excluded hy-
percoagulability. In fact, homocystein, LAC screen, SCT screen,
protein C and S, APCR, Factor V Leyden, ACA, ANA, and ENA
antibodies were negative. MTHFR mutation C677T was present
in heterozygosis. DUS demonstrated the fibrotic involution of
GSV trunk. The proximal border of GSV occlusion was at about 4
cm from the saphenous ending and 2 cm from the orifice of the
inferior epigastric (Fig 2).
DISCUSSION
Previous reports have claimed efficacy and overall safety
of EVLT. Bruising and a “pulling” sensation along the
inner thigh are common side-effects of EVLT.5 The overall
rate of minor-complication, skin burn injuries, induration,
self-limited superficial phlebitis, and skin pigmentation
ranges between 0% and 15%.5 Major non-thrombotic com-
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venous fistula,6 and diffuse phlegmonous hypodermitis7
are seldom reported. To our knowledge, no pulmonary
embolism (PE) or stroke have been described. PE has been
described after radiofrequency ablation of the GSV11 and a
Fig 1. Brain computed tomography performed without contrast
on April 21.
Fig 2. Color Duplex scanning demonstrating the patency of the
saphenous vein stump (*) and of the inferior epigastric vein
(arrow).transient stroke after foam sclerotherapy of the GSV.14Prevalence of DVT after EVLT ranges between 0% and
7.7% for the GSV8 and between 0% and 5.7% for the small
saphenous vein (SSV).9 Differences in rates of DVT are
probably related to different timing of post operative
DUS.8 In fact, EVLT-DVT consists of a tail of thrombus
extending into the femoral vein10 or even of a floating
thrombus,11 which would develop in the first postoperative
days to possibly regress later.8 Since femoral and popliteal
veins are incompletely occluded by the thrombus, EVLT-
DVT is mostly asymptomatic and can be evidenced only by
DUS.8-10 Therefore, prevalence of DVT is higher in studies
with early post-procedure DUS.7-11 On the contrary, most
studies which timed the first DUS at a longer distance to
evaluate long-term efficacy of EVLT did not evidence
DVT.12,13
In the reported case, an ischemic stroke occurred five days
after EVLT of the right GSV due to embolic occlusion of the
left MCA. No evident sources of emboli could be demon-
strated at heart and carotid levels, whereas TEE demonstrated
PFO. Duplex was negative for leg DVT but it was performed
only 14 days after EVLT. The patient was not afflicted by any
malignancies or other pro-thrombotic conditions.
In the absence of any other obvious source, it is
strongly suspected that the stroke resulted from paradoxical
embolism from the operated leg through PFO. The tem-
poral relationship of the incident and the TCD findings
lends further support to this.8-11
The development of the saphenic thrombus looks to be
not prevented by withdrawing the probe distal to the
inferior epigastric vein, this precaution being adopted by all
current protocols including the reported case. Moreover,
the supra-inguinal location of these thrombi makes postop-
erative compression ineffective at all.
This case illustrates a major, potentially fatal complica-
tion of treatment for a benign condition due to an un-
known PFO. Routine transthoracic echocardiography may
fail to demonstrate a PFO, which exact evaluation needs
TEE with bubble test. In order to prevent thromboembolic
complications, systematic LMWH administration for seven
days was proposed.9,11 We have preferred to advance the
first DUS at the fourth postoperative day to possibly inter-
vene during early thrombus development. Further studies
are required to possibly determine: 1) The cause of cranial
extension of the saphenic EVLT-induced thrombus; 2) which
patients are at higher risk of DVT, and 3) if prophylactic
anticoagulation11 or combined high ligation15 are war-
ranted, at least in selected patients.
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